CSI Market
Sign In | Register

Mineralys Therapeutics Inc (MLYS) Annual Balance Sheets

Annual · GAAP · USD millions
Access MLYS quarterly Balance Sheets →
Examining balance sheet movements between Mineralys Therapeutics Inc and reveals how Dec 31 2025 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MLYS/balance-sheets
https://api.csimarket.com/api/v1/companies/MLYS/fundamentals
https://api.csimarket.com/api/v1/companies/MLYS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent172.92
Combined Cash+Investments Total (filer-reported)656.60
Cash & Short-term Investments172.00
Other Current Assets483.71
Prepaid Expense And Other Assets Current4.75
Total Current Assets661.39
Equipment/Property/Plant Net0.04
Other Assets, Noncurrent0.38
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current-
Debt Securities Current483.71
Total Assets661.81
Liabilities
Accounts Payable, Current AC2.02
Accrued Liabilities, Current AC13.10
Other Liabilities, Current0.00
Total Current Liabilities15.11
Total Long-term Debt0.00
Total Liabilities15.11
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,103.85
Retained Earnings / Accumulated Deficit-457.17
Other Equity0.00
Common Stockholder's Equity646.69
Total Stockholder's Equity646.69
Liabilities & Stockholder's Equity661.81
4 historic quarters locked

Sign in to unlock the full Mineralys Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Mineralys Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001933414-26-000056

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI